ResMed Market Sentiment

ResMed Inc

RMDNYSE

$250.80

-2.40-0.95%

Últ. Act.: Oct 27, 4:19 PM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Dividendos Comparar Opciones Informe de acciones

Ganancias: Los beneficios de Q1 2027 mañana en jue oct 29th después del cierre del mercado

Conferencia telefónica: Conferencia telefónica programada para mañana a las 4:30 p. m.

Haz clic para ver el webcast

ResMed Market Sentiment - Benzinga

ResMed Market Sentiment

Market sentiment signals for ResMed (RMD): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Neutral

Short Interest▲ 10.2% short float

Options Flow▼ 18.13 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Neutral

21 analysts

Options Flow (P/C)

18.13

More puts — Bearish

30 calls · 544 puts

Avg Consensus PT

$246

-2.9%

Highest Price Target

$325

+28.5%

UBS

Lowest Price Target

$180

-28.8%

Wolfe Research

Short Interest

10.2%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 15, 2026	RBC Capital	Craig Wong-Pan—	+3.6%	$244 → $262	Upgrade	Sector Perform→Outperform
Aug 31, 2026	Keybanc	Brett Fishbin—	+5.6%	$255 → $267	Maintained	Overweight
Aug 19, 2026	Rothschild & Co	Jackson Philips—	-9.0%	$230	Initiate	Neutral
Aug 7, 2026	RBC Capital	Craig Wong-Pan—	-3.5%	$234 → $244	Maintained	Sector Perform
Aug 7, 2026	Piper Sandler	Adam Maeder—	-11.0%	$233 → $225	Maintained	Neutral
Aug 7, 2026	Keybanc	Brett Fishbin—	+0.9%	$260 → $255	Maintained	Overweight
Aug 7, 2026	Wells Fargo	Nathan Treybeck—	-15.0%	$225 → $215	Maintained	Equal-Weight
Jul 15, 2026	Mizuho	Anthony Petrone—	-13.0%	$235 → $220	Maintained	Outperform
Jul 13, 2026	Citigroup	Laura Sutcliffe—	-7.1%	$270 → $235	Downgrade	Buy→Neutral
Jul 10, 2026	Jefferies	Matthew Taylor—	-11.0%	$240 → $225	Maintained	Hold
Jul 8, 2026	RBC Capital	Craig Wong-Pan—	+9.2%	$321 → $276	Maintained	Outperform
Jul 8, 2026	Wells Fargo	Nathan Treybeck—	-11.0%	$227 → $225	Maintained	Equal-Weight
Jun 22, 2026	Keybanc	Justin Patterson—	+5.2%	$290 → $266	Maintained	Overweight
Jun 17, 2026	Morgan Stanley	David Bailey—	-9.0%	$286 → $230	Downgrade	Overweight→Equal-Weight
Jun 15, 2026	Citigroup	Laura Sutcliffe—	+6.8%	$340 → $270	Maintained	Buy
May 1, 2026	RBC Capital	Craig Wong-Pan—	+27.0%	$314 → $321	Maintained	Outperform
May 1, 2026	Wells Fargo	Nathan Treybeck—	-10.2%	$270 → $227	Maintained	Equal-Weight
Apr 27, 2026	Keybanc	Brett Fishbin—	+14.7%	$302 → $290	Maintained	Overweight
Apr 15, 2026	JP Morgan	David Low—	—	—	Reinstates	Overweight
Apr 9, 2026	Citigroup	Laura Sutcliffe—	+34.5%	$345 → $340	Maintained	Buy
Feb 2, 2026	Citigroup	Laura Sutcliffe—	+36.4%	$330 → $345	Maintained	Buy
Jan 30, 2026	RBC Capital	Craig Wong-Pan—	+24.2%	$311 → $314	Maintained	Outperform
Jan 30, 2026	Piper Sandler	Adam Maeder—	+8.8%	$270 → $275	Maintained	Neutral
Jan 30, 2026	Wells Fargo	Nathan Treybeck—	+6.8%	$265 → $270	Maintained	Equal-Weight
Jan 30, 2026	Stifel	Jonathan Block—	+4.8%	$260 → $265	Maintained	Hold